Key statistics
As of last trade United Therapeutics Corp (U2TH34:SAO) traded at 108.01, -10.79% below its 52-week high of 121.08, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 109.12 |
---|---|
High | 109.12 |
Low | 108.01 |
Bid | 107.69 |
Offer | 108.46 |
Previous close | 105.30 |
Average volume | 67.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Nov 22 2024 17:15 GMT.
More ▼
Press releases
- United Therapeutics Corporation to Present at the UBS Global Healthcare Conference
- United Therapeutics Corporation Reports Third Quarter 2024 Financial Results
- United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service
- United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024
- United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting
- United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever
- United Therapeutics Corporation to Present at Upcoming Investor Conferences
More ▼